ARQ-234

· Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ-234, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 [Phase 1]